Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 44% ± 12% | |
| type I pneumocyte | 7 studies | 42% ± 15% | |
| squamous epithelial cell | 4 studies | 38% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 95% | 667.32 | 621 / 653 | 76% | 637.61 | 460 / 605 |
| lung | 93% | 551.85 | 536 / 578 | 51% | 47.19 | 590 / 1155 |
| ureter | 0% | 0 | 0 / 0 | 100% | 856.64 | 1 / 1 |
| skin | 79% | 11596.89 | 1430 / 1809 | 11% | 26.65 | 53 / 472 |
| esophagus | 36% | 312.66 | 525 / 1445 | 43% | 30.55 | 78 / 183 |
| blood vessel | 77% | 503.02 | 1033 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 1.99 | 2 / 328 | 71% | 95.88 | 126 / 178 |
| uterus | 4% | 19.48 | 6 / 170 | 62% | 69.92 | 285 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 38.86 | 28 / 45 |
| bladder | 5% | 8.67 | 1 / 21 | 56% | 127.77 | 283 / 504 |
| ovary | 1% | 1.84 | 2 / 180 | 52% | 23.94 | 225 / 430 |
| breast | 2% | 3.58 | 8 / 459 | 44% | 22.37 | 489 / 1118 |
| kidney | 11% | 25.76 | 10 / 89 | 14% | 10.57 | 122 / 901 |
| intestine | 0% | 0.27 | 1 / 966 | 11% | 23.03 | 57 / 527 |
| adipose | 11% | 35.20 | 129 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 2% | 3.56 | 7 / 359 | 7% | 4.58 | 21 / 286 |
| prostate | 3% | 10.78 | 8 / 245 | 6% | 2.60 | 30 / 502 |
| heart | 6% | 13.40 | 53 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 1.54 | 1 / 226 | 2% | 1.27 | 7 / 406 |
| brain | 0% | 0.65 | 10 / 2642 | 1% | 0.11 | 4 / 705 |
| muscle | 1% | 5.06 | 5 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.12 | 1 / 230 |
| peripheral blood | 0% | 0.16 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0008544 | Biological process | epidermis development |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0001533 | Cellular component | cornified envelope |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CST6 |
| Protein name | Cystatin-M (Cystatin-6) (Cystatin-E) CST6 protein |
| Synonyms | |
| Description | FUNCTION: High affinity inhibitor for cathepsin L, cathepsin L2 (cathepsin V), and legumain . Involved in the regulation of epidermal cornification, and hair follicle morphogenesis and maintenance . . |
| Accessions | ENST00000312134.3 Q6IBD2 Q15828 |